News | March 17, 2024
Eris Lifesciences buys India formulation business of Biocon Biologics for Rs. 1,242 Cr
Both organisations enter into a long- term collaboration to expand patient access in India
Both organisations enter into a long- term collaboration to expand patient access in India
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
ANVISA issues CGMP to Concord Biotech’s Unit I
Acquisition of exclusive commercialization rights for European markets
The proposed hospital will have a bed capacity of 300 beds and the investment in the project is expected to be around Rs. 500 crore
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
VeerHealth Care will be raising Rs. 8 crores through bank borrowings
The board gave in-principle approval for expansion of company's footprint in Lucknow
Subscribe To Our Newsletter & Stay Updated
